top of page


Co-Founder, Watchmaker Genomics

Trey applies pioneering methods in directed evolution and enzyme engineering to enable novel genomic applications. As Co-Founder and former Chief Technology Officer of Kapa Biosystems, Trey led the company’s global commercial and scientific teams in the development of high-growth, innovative products for next-generation sequencing (NGS), qPCR and PCR. Following the acquisition of Kapa Biosystems by Roche in 2015, Trey served as Vice President of Sequencing and Life Science Commercial Operations for Roche North America. He is listed as an inventor on 3 issued patents and 2 pending patents.

bottom of page